Expert Pitch
Virginia Tech

Mental health expert available to discuss tips for easing COVID-19 anxiety

19-Mar-2020 8:45 AM EDT, by Virginia Tech

The spread of the coronavirus throughout the world has many people feeling anxious, which is normal in this time of uncertainty, explains Dr. Robert Trestman, head of psychiatry at the Virginia Tech Carilion School of Medicine.

“It is a normal, healthy response to be anxious when confronted with a pandemic such as COVID-19. Our challenge is to remember that there is a lot under our control to reduce risks for ourselves, our families, and our communities,” said Dr. Trestman.

Dr. Trestman offers the following helpful tips to ease anxiety during this time.

  • Discuss how you are feeling with friends and family.
  • Educate yourself about the virus and steps to take to protect yourself.
  • Take breaks from watching the news about the pandemic.
  • Take preventive efforts to use good hygiene: wash your hands - a lot!
  • Follow recommendations from health professionals.
  • Use social media to stay in touch with friends and family.
  • Structure your day to include both productive activities and some things that you simply enjoy.
  • For those who seek regular mental health care, use telemedicine to continue care.

About Trestman

Robert Trestman is professor and chair of the Carilion Clinic and Virginia Tech Carilion School of Medicine Department of Psychiatry and Behavioral Medicine. Dr. Trestman has studied the neurobiology and treatment of people with severe mood and personality disorders and conducts translational research on mental health. He has authored over 180 peer reviewed articles and other publications and is the senior editor of the first textbook in the field of correctional psychiatry, the Oxford Textbook of Correctional Psychiatry. Dr. Trestman is the co-developer of START NOW, a skills-based psychotherapy in use in five countries. He has given over 150 regional, national, and international invited presentations. More here.

Interview

To secure an interview with Trestman, contact Shannon Andrea in the media relations office at sandrea@vt.edu or 703-399-9494.




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
1.94247